US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

71.78

+1.151.63%

Post-market: 70.64-1.1482-1.60%16:10 EDT

Volume:16

Turnover:1K

Market Cap:717.92K

PE:- -

High:71.78

Open:70.64

Low:71.78

Close:70.64

52wk High:85.03

52wk Low:56.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.05

T/O Rate:0.16%

Dividend:2.08

Dividend Rate:2.89%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK’s New COPD Bet: Felcorekibart Enters Phase 3 With Long-Term Upside Potential

GSK’s New Phase 3 Asthma Trial Sets the Stage for the Next Wave in Respiratory Growth

BMO starts Exelixis at Market Perform into patent cliff

GSK Executives Add ADS Through Dividend Reinvestment Plans

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

GSK Executives Acquire Shares Under Company Reward Plan

Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure

Global Drugmakers Invest Billions to Boost US Presence

GSK Discloses Executive Notional ADS Acquisition by U.S. President

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Global Drugmakers Invest Billions to Boost US Presence

GSK’s NEBULA-1 MASH Cirrhosis Trial: A New Catalyst in Metabolic Liver Disease

GSK's New Drug Launches Will be Key to 2027 Outlook

GlaxoSmithKline (GSK) Receives a Sell from Barclays

GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum

GSK Supply Chain President Registers Sale of Ordinary Shares

GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment

MT Newswires Live

Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/GSKH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":71.7846,"timestamp":1789675200000,"preClose":70.6364,"halted":0,"volume":16,"hourTrading":{"tag":"盘后","latestPrice":70.6364,"preClose":71.7846,"latestTime":"16:10 EDT","volume":6,"amount":430.7076,"timestamp":1789675804131,"change":-1.1482,"changeRate":-0.015995,"amplitude":0},"delay":0,"changeRate":0.01625507528696257,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Not Yet Opened","change":1.1482,"latestTime":"09-17 16:00:00 EDT","open":70.6364,"high":71.7846,"low":71.7846,"amount":1130,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":70.6364,"nav":70.29546,"aum":703024.89546,"dividendRate":0.02893,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":70.6364,"preClose":71.7846,"latestTime":"16:10 EDT","volume":6,"amount":430.7076,"timestamp":1789675804131,"change":-1.1482,"changeRate":-0.015995,"amplitude":0},"volumeRatio":0.046702,"impliedVol":0.2137,"impliedVolPercentile":0.7179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.046702,"shares":10001,"dividePrice":2.0767,"high":71.7846,"amplitude":0,"preClose":70.6364,"low":71.7846,"week52Low":56.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":71.7846,"eps":0,"divideRate":0.02893,"volume":16,"delay":0,"ttmEps":0,"open":70.6364,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":67.0681,"twentyDayClose":73.0903,"sixtyDayClose":73.662},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661629484","title":"GSK’s New COPD Bet: Felcorekibart Enters Phase 3 With Long-Term Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2661629484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661629484?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:32","pubTimestamp":1787329951,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The PERSIST COPD-1 trial from GlaxoSmithKline tests GSK5784283, also ca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-copd-bet-felcorekibart-enters-phase-3-with-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-copd-bet-felcorekibart-enters-phase-3-with-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","BK4532","GSK.UK","GSK","LU1829250122.USD","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661874294","title":"GSK’s New Phase 3 Asthma Trial Sets the Stage for the Next Wave in Respiratory Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661874294","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661874294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:32","pubTimestamp":1787329944,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The PERSIST ASTHMA-1 study, officially titled a Phase 3 randomized tria...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-asthma-trial-sets-the-stage-for-the-next-wave-in-respiratory-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-asthma-trial-sets-the-stage-for-the-next-wave-in-respiratory-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4585","GSK","GSKH","BK4007","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492411","title":"BMO starts Exelixis at Market Perform into patent cliff","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492411?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:30","pubTimestamp":1787085023,"startTime":"0","endTime":"0","summary":"BMO Capital initiated coverage of Exelixis (EXEL) with a Market Perform rating and $54 price target Exelixis is anchored by cabozantinib, a “durabl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","BME","EXEL","IYH","LU2272731865.HKD","PJP","APXH","IE00B5TLWC47.USD","GSKH","SYNB","FHLC","RXL","LU1992135399.USD","BK4207","FXH","IHE","LU2272731782.SGD","BMO","LU2322448791.USD","PBPH","BK4532","BBH","BK4588","RXD","AZNH","CURE","LU2272731600.USD","LU2473716301.USD","IBB","XPH","TRUH","FTXH","PPH","MEDX","LU1992135472.HKD","LU2322448957.HKD","BK4585","USRD","FBT","MEDI","RSPH","BK4139","TMED","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660493225","title":"GSK Executives Add ADS Through Dividend Reinvestment Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2660493225","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660493225?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:33","pubTimestamp":1787063592,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK disclosed several routine share transactions by senior executives involving the acqui...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-add-ads-through-dividend-reinvestment-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-add-ads-through-dividend-reinvestment-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","GSK","GSKH","BK4532","LU1829250122.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660323436","title":"European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660323436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660323436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:12","pubTimestamp":1786979555,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week tracking modestly higher late Monday morning, rising 0.31% to 1,970.56 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and DBV Technologies , which climbed 16% and 5.1% respectively. They were followed by telecommunications company Nokia  and biopharmaceutical company Cellectis , which advanced 2.5% and 2% respectively.The decliners from continental Europe were led by medical device maker EDAP TMS  and internet browser company Opera , which dropped 4.6% and 2.7% respectively. They were followed by brewing company Anheuser-Busch InBev  and consumer goods company Unilever , which lost 2.4% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and biopharmaceutical company Akari Therapeutics , which rose 6.3% and 2.8% respectively. They were followed by biopharmaceutical companies GSK  and Bicycle","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MREO","IBB","BK4592","UN","IE0002141913.USD","NOK","UL","AUTL","BUD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0006061336.USD","DGE.UK","AKTX","GSK","OPRA","BCYC","BK4505","BUD.AU","BK4117","DBVT","GSKH","BK4107","WPP.AU","CLLS","ULVR.UK","EPV","TBXU","BK4532","DEO","IEUR","NCNA","FOCL","ARGX","IE00BFTCPJ56.SGD","IE00BMPRXN33.USD","WPP","BK4139","GSK.UK","LNOK","IE00B4R5TH58.HKD","BK4007","LU0823416689.USD","BK4588","BK4169","FMED","LFGY","AFG","BK4009","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601881","XLVI","BK1564","BK1147","BIOY","BK0276","161027","BK0188","06881","IBB","SBIO","WRND","BK4588","PBE","GDOC","GSKH","BK4585","BBP","APXH","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659642163","title":"GSK Executives Acquire Shares Under Company Reward Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659642163","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659642163?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:37","pubTimestamp":1786631844,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has disclosed a series of routine share dealings by several senior executives, i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-company-reward-plan-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-company-reward-plan-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSKH","GSK","BK4532","BK4585","GSK.UK","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142463773","title":"Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=1142463773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142463773?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:10","pubTimestamp":1786543834,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) issued a statement on August 12, revealing that its stock price has experienced an unusual surge, with cumulative closing price gains exceeding...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0102","GDOC","BIOY","SBIO","WRND","BK4588","PBE","BK4585","APXH","XLVI","600721","LFSC","IBB","BK0216","GSKH","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911015","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911015?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:57","pubTimestamp":1786463857,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 11 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44815K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168563687.JPY","AMGN","LU2236285917.USD","IE00BJJMRX11.SGD","NVOX","LU2471134796.USD","LU0265550359.USD","LU0980610538.SGD","IE0009355771.USD","LU2211815571.USD","IE0005OL40V9.USD","IE0000B7K699.USD","NVO","IE00BVYPNV92.GBP","BMED","LU0323591593.USD","LU0098860793.USD","LU0432979614.USD","LU1267930573.SGD","LU1244550494.USD","LU0130102774.USD","LU2213496289.HKD","LU0466842654.USD","LU2471134952.CNY","LU2125154935.USD","LU0868494617.USD","LU0689472784.USD","LU0130517989.USD","LU0889566641.SGD","SG9999015945.SGD","SG9999015986.USD","BK4534","LU1035773651.USD","IE00B7SZLL34.SGD","LU1814569148.SGD","LU2089284900.SGD","LU1551013425.SGD","LU2430703095.HKD","SG9999014567.USD","LU0061475181.USD","IE00B19Z9P08.USD","LU1720051108.HKD","LU2271345857.HKD","SGXZ31699556.SGD","LU1585245621.USD","SG9999014898.SGD","FHLC","BK4516","IE00BN29S564.USD","IE00B894F039.SGD","IE0004445015.USD","LU0029864427.USD","LU0198837287.USD","LU0985481810.HKD","03165","SG9999014914.USD","LU1868836591.USD","LU2237443895.HKD","LU2756315664.SGD","LU1032955483.USD","LU1989772840.SGD","LLYZ","LU0792757196.USD","LU1917777945.USD","IE00BLSP4239.USD","VHT","LU1043141396.HKD","XLV","LU2129689431.USD","LU2324357040.USD","IE00BBT3K403.USD","LU2491050071.SGD","LU0096364046.USD","LU1670628061.USD","IE0002270589.USD","LU0320765992.SGD","LU1720051017.SGD","BK4599","SG9999013999.USD","IE00BK4W5M84.HKD","LU1894683264.USD","IE00BJJMRY28.SGD","LU2430703251.USD","LU0965508806.USD","LU2456880835.USD","LU2129689605.HKD","LU1366192091.USD","LU0170899867.USD","LU2106854487.HKD","LU2237443549.SGD","LU2357305700.SGD","LU0545039389.USD","IE00B7KXQ091.USD","LU0203202063.USD","LU0079474960.USD","LU0964807845.USD","BK4578","BK7067","BK4139","SG9999015952.SGD","LU0094547139.USD","LU0289961442.SGD","LU0310799852.SGD","LU0256863811.USD","IE00B42XCP33.USD","GDOC","LU0203347892.USD","LU1037948541.HKD","SG9999001440.SGD","IE00B3PB1722.GBP","LU1548497426.USD","LU1571399168.USD","LU1069344957.HKD","LU1196500208.SGD","LU1929549753.HKD","LU2237443978.SGD","LU2168564065.EUR","PBE","LU2125909247.SGD","LU2756315318.SGD","LU0868494708.USD","LU0708995401.HKD","LU1551013342.USD","LU1988902786.USD","LU0820561909.HKD","LU0889565916.HKD","LU0472753341.HKD","LU2746668461.USD","LU0114720955.EUR","LU2112291526.USD","IE00B1XK9C88.USD","BK4581","LU0820562030.AUD","LU1934455863.HKD","LU0289739343.SGD","SG9999014880.SGD","LU0210536198.USD","CANC","LU0321505439.SGD","LU0820561818.USD","AZN","IE000SO60NU8.SGD","LU1267930490.SGD","ABBV","LU0823434583.USD","LU2417539215.USD","LU1941712348.USD","LU1066051225.USD","IE0001KFT4U8.USD","LU0225283273.USD","SG9999014542.SGD","LU0965509010.AUD","RXL","BK4588","LU2357627491.SGD","IE00B775H168.HKD","LU0511384066.AUD","LU1244550221.USD","LU1023059063.AUD","LU0225771236.USD","LU0345770993.USD","RHHBY","LU2592432038.USD","LU2125154778.USD","LU2133065610.SGD","LU2028103732.USD","LU1868836757.USD","IHE","IE00BKDWB100.SGD","IE00BKPKM429.USD","SG9999002232.USD","CURE","IE0034235303.USD","LLY","LU2505996681.GBP","LU0738911758.USD","LU2430703178.SGD","LU1145028129.USD","LU2750360997.AUD","BK4007","BK4559","LU1061106388.HKD","LU2462591350.SGD","SG9999014559.SGD","LU2237443465.HKD","LU0949170772.SGD","LU2087621335.USD","BK4504","IE00BVYPNW00.USD","BK7501","SG9999001176.USD","SGXZ80539844.SGD","LU1974910355.USD","LU1261432733.SGD","LU2237438978.USD","LU1057294990.SGD","LU0316494557.USD","LU0174119429.USD","IE00BSNM7G36.USD","BK7508","IE000F7OJYX1.SGD","LU1934455277.USD","04332","LU0238689110.USD","LU2602419157.SGD","LU0069063385.USD","LU1941712264.USD","IE000M9KFDE8.USD","LU1228905540.USD","LU2089984988.USD","LU0417517546.SGD","IE00BWXC8680.SGD","LU1670627923.USD","LU0640476718.USD","IE00BKVL7J92.USD","LU0353189763.USD","TBXU","BK4533","LU0122379950.USD","LU2552382058.USD","LU1059921491.USD","SG9999014575.USD","NVS","LU2750360641.GBP","LU1066051498.USD","LU2462157665.USD","LU2471134879.HKD","IE00B4R5TH58.HKD","LU1989771016.USD","LU2403377893.USD","SG9999017495.SGD","LU0426417589.USD","SGXZ51526630.SGD","IYH","LU0942090050.USD","LU2461242641.AUD","MHIP","LU0345770308.USD","LU1670711123.USD","TMED","IE00B19Z3581.USD","LU0320765489.SGD","MRK","LU2265009873.SGD","IE00BFXG1179.USD","LU1699723380.USD","LU1804176565.USD","LLYX","LU0354030511.USD","LU0154236417.USD","LU1935042991.SGD","LU2491049909.HKD","LU0426412945.USD","LU2468319806.SGD","LU1868837300.USD","LU2125909593.SGD","LU1496350502.SGD","LU0859254822.USD","LU2491050154.USD","LU1127390331.HKD","LU0006306889.USD","SG9999001176.SGD","LU2063271972.USD","LU0128525929.USD","MEDI","LU0053666078.USD","LU2552382215.SGD","LU1162221912.USD","LU1037948897.HKD","SGXZ99366536.SGD","IE00B3T34201.USD","LU0211327993.USD","LU0882574055.USD","BIIB","LU1221951046.USD","SG9999018865.SGD","LU0395794307.EUR","GLAM","LU0234570918.USD","LU0471298777.SGD","LU1914381329.SGD","LU0070302665.USD","LU0726765562.USD","LU1670711040.USD","GB00BDT5M118.USD","SG9999018857.SGD","IE00BK4W5L77.USD","HRTS","LU1074936037.SGD","LU1221951129.SGD","IE000MB6IJN5.SGD","SG9999014906.USD","LU2242646821.SGD","PJP","LU0256863902.USD","BK4532","LU1228905037.USD","LU1934455194.USD","THNR","JDOC","LU2361044949.HKD","LU2023250504.SGD","LU2433249047.HKD","LU1983299246.USD","LU1778281490.HKD","BK4568","LU1066053197.SGD","LU1506573853.SGD","CSL.AU","LU0795875086.SGD","LU1093756325.SGD","LU0210528500.USD","AZNH","LU0661504455.SGD","SG9999003800.SGD","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","PAWZ","JNJ","LU0786609619.USD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU1116320901.HKD","LU2111349929.HKD","LU0211331839.USD","IE0004445239.USD","LU0106261372.USD","LU0965509101.SGD","LU1883839398.USD","AGNG","LU0237698245.USD","LU0266013472.USD","LU1232071149.USD","LU2596442595.SGD","LU2361044865.SGD","LU0289739699.SGD","LU1093756168.USD","LU0310800379.SGD","LU1629891620.HKD","LU1035775433.USD","IE00BJT1NW94.SGD","SNY","BK4585","ILDR","LU0203201768.USD","IE00B19Z9Z06.USD","BK4550","LU1066051811.HKD","BK4592","LU1430594728.SGD","LU1674673428.USD","PFE","LU0648001328.SGD","GSKH","NVOH","LU0208291251.USD","IE000BZT7R73.USD","IE00B2B36J28.USD","LU0795875169.SGD","GSK","LU1670710661.SGD","LU2360106947.USD","LU1674673691.USD","LU2237443382.USD","LU2360032135.SGD","LU0354030438.USD","SG9999015358.SGD","LU0965509283.SGD","LU1116320737.USD","LLII","LU0683600562.USD","LU0787776722.HKD","LU0057025933.USD","LU2746668974.SGD","IXJ","TRUH","ELIS","LU1868837136.USD","GSK.UK","LU0109391861.USD","LU1732800096.USD","LU0861579265.USD","LU2129689514.USD","LU1244550577.SGD","LU0553294199.USD","LU2242652126.USD","IE00BZ1G4Q59.USD","LU1670710588.SGD","LU1923622614.USD","LU1894683348.USD","LU1718418525.SGD","LU1032466523.USD","LU2087625088.SGD","LU0477156953.USD","LU1064131342.USD","LU2089283258.USD","LU2487616109.SGD","PPH","LU0058720904.USD","LU0070217475.USD","IE00B1BXHZ80.USD","LU2237443622.USD","LU0321505868.SGD","LU0234572021.USD","LU2023250843.SGD","LU0306806265.USD","LU0320765059.SGD","LU1003077747.HKD","SG9999002224.SGD","LU0109394709.USD","LU0203345920.USD","LU1868836914.USD","LU0133085943.USD","IE00B4JS1V06.HKD","LU1732799900.SGD","LU1989772923.USD","LU0672654240.SGD","LU2264538146.SGD","WDNA","LU2361045086.USD","LU0385154629.USD","IE00B19Z3B42.SGD","BK7511","SG9999015341.SGD","LU1267930730.SGD","LU1829250122.USD","LU1291159041.SGD","FTXH","BK4566","LU2023251221.USD","LU2552382132.HKD","LU2896262040.SGD","BBH","IE00BFSS8Q28.SGD","LU0124676726.USD","IE00BDGV0183.EUR","LU2347655156.SGD","LU0456855351.SGD","BIB","LU1323610961.USD","LU0265550946.USD","LU0912757837.SGD","LU0162691827.USD","GILD","LU0320765646.SGD","BMY","LU1121112475.USD","IBB","LU2505996509.AUD","SGXZ57979304.SGD","IBBQ","LU2471134523.USD","LU2168564495.EUR","LU0097036916.USD","IE00BJLML261.HKD","LU0943347566.SGD","LU1043141123.HKD","LU0708994859.HKD","OZEM","LU2023250330.USD","LU1069347547.HKD","IE0002141913.USD","LU2347655073.USD","LU0985320562.USD","LU2108987350.USD","LU0345769128.USD","LU2168564149.EUR","SGXZ81514606.USD","SG9999015978.USD","ELIL","LU0823434740.USD","LU1280957306.USD","LU0267386448.USD","LU1496350171.SGD","BK4583","IE000WAW04H5.SGD","SG9999011175.SGD","LU0471298694.HKD","LU1979441026.SGD","LU0306807586.USD","LU0345769631.USD","LU0823416689.USD","LU0353189680.USD","LU0211328371.USD","IE00BFSS7M15.SGD","IE00BLSP4452.SGD","LU0882574139.USD","LU1712237335.SGD","LU1267930813.SGD","LU1623119135.USD","IE00BGHQF631.EUR","LU0545562505.USD","LU0072461881.USD","LU0689626769.HKD","LU0994945656.USD","LU1839511570.USD","LU2168564222.USD","MEDX","LU0158827781.USD","LU0158827948.USD","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919943","title":"GSK Discloses Executive Notional ADS Acquisition by U.S. President","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919943","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919943?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:32","pubTimestamp":1786458751,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK plc disclosed a transaction involving Maya Martinez-Davis, its President for the U.S....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-executive-notional-ads-acquisition-by-u-s-president-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-executive-notional-ads-acquisition-by-u-s-president-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4007","BK4588","GSKH","LU1829250122.USD","BK4532","BK4585","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174341976","title":"Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1174341976","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174341976?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450094,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) has issued a stock trading risk warning announcement, stating that it is a CRO enterprise primarily focused on the research and development of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","PBE","BK4588","BBP","BK0216","BK4585","IBB","WRND","APXH","SBIO","600721","XLVI","BIOY","GDOC","GSKH","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118729610","title":"AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1118729610","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118729610?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:12","pubTimestamp":1786428745,"startTime":"0","endTime":"0","summary":"A research report from Orient Securities Company Limited highlights that as global regulatory shifts accelerate, the large-scale application of AI in pharmaceuticals is rapidly advancing. It has...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","03958","BK1147","BK4588","IBB","LFSC","BK0012","VTHR","SBIO","GDOC","AIPO","BK1564","WRND","BK0028","BK0188","QTOC","600958","CHAT","BK4585","ARTY","PBE","BBP","AGIX","APXH","GSKH","XLVI","BIOY","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931607","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:16","pubTimestamp":1786367800,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 10 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","IE00BN29S564.USD","IE00BKPKM429.USD","IE000F7OJYX1.SGD","LU2430703251.USD","LU1868836591.USD","LU2403377893.USD","BK7501","MHIP","IE00BWXC8680.SGD","LU0053666078.USD","LU2264538146.SGD","LU0395794307.EUR","LU0106261372.USD","LU0823416689.USD","LU0426417589.USD","CURE","BK4568","LU2265009873.SGD","LU2552382132.HKD","MEDX","LU1868836757.USD","LU2505996509.AUD","IE00B4R5TH58.HKD","THNR","LU2471134879.HKD","LU0316494557.USD","LU0211328371.USD","LU0122379950.USD","LU0128525929.USD","IE00B19Z3B42.SGD","LU1979441026.SGD","BBH","LU0079474960.USD","LU2089984988.USD","LU1868837300.USD","IE00B19Z9Z06.USD","LU1983299246.USD","LU1551013425.SGD","LU1894683264.USD","IE00BJLML261.HKD","SG9999018865.SGD","LU0130517989.USD","LU0174119429.USD","LU1670711040.USD","LU0267386448.USD","LU2168564065.EUR","LU0256863811.USD","LU2168563687.JPY","LU1718418525.SGD","LU2433249047.HKD","IE0000B7K699.USD","LU0354030438.USD","LU0070302665.USD","LU1267930573.SGD","LU0006306889.USD","IE00BLSP4452.SGD","LU0353189763.USD","SGXZ99366536.SGD","LU1934455277.USD","SG9999001176.USD","LU0225283273.USD","LU0310800379.SGD","AZNH","LU2324357040.USD","LU0069063385.USD","LU1548497426.USD","LU0965509010.AUD","IE00BGHQF631.EUR","LU1883839398.USD","LU2602419157.SGD","LU0323591593.USD","LU1989771016.USD","SGXZ80539844.SGD","LU0912757837.SGD","LU0130102774.USD","LU1814569148.SGD","LU2237443382.USD","BK4588","LU2491050154.USD","LU2087625088.SGD","04332","IE00B1BXHZ80.USD","LU1732799900.SGD","LU2750360997.AUD","LU0889566641.SGD","IE00B2B36J28.USD","SG9999017495.SGD","LU0726765562.USD","BK4585","LU0162691827.USD","LU0170899867.USD","CANC","LU0029864427.USD","PJP","MEDI","SG9999002232.USD","LU2746668974.SGD","ILDR","SG9999014542.SGD","LU0708994859.HKD","LU0289739699.SGD","LU0456855351.SGD","LU2129689514.USD","LU0070217475.USD","LU1093756325.SGD","BK7508","LU2596442595.SGD","GILD","LU1035773651.USD","LU2211815571.USD","LU0661504455.SGD","LU2125909247.SGD","BIB","LU1941712348.USD","LU2487616109.SGD","LU1989772923.USD","LU1629891620.HKD","LU2168564495.EUR","LU0949170772.SGD","LU1732800096.USD","LU2552382215.SGD","SG9999014575.USD","LU1670710588.SGD","LU0823434740.USD","IE00B19Z3581.USD","LU1244550221.USD","LU2111349929.HKD","LLY","LU1720051017.SGD","IE00BZ1G4Q59.USD","LU1988902786.USD","LU2237438978.USD","IE00B3T34201.USD","IE000WAW04H5.SGD","LU0672654240.SGD","LU0965509283.SGD","LU1929549753.HKD","GSK.UK","LU1280957306.USD","LU1066053197.SGD","IE00BDGV0183.EUR","LU0266013472.USD","LU0211327993.USD","SG9999018857.SGD","LU1670628061.USD","SG9999015952.SGD","SGXZ31699556.SGD","LU2357627491.SGD","LU2125154778.USD","LU1923622614.USD","LU0225771236.USD","LU1228905540.USD","LU2242646821.SGD","LU1712237335.SGD","JDOC","LU0787776722.HKD","ELIS","LU1941712264.USD","PPH","SG9999001440.SGD","LU2361044865.SGD","LU1066051811.HKD","LU0238689110.USD","SG9999015986.USD","LLII","LU2063271972.USD","LU0345770993.USD","LU0859254822.USD","LU0985481810.HKD","LU2430703095.HKD","LU1571399168.USD","LU2023250330.USD","IE0004445015.USD","LU0511384066.AUD","LU1093756168.USD","LU2023250843.SGD","LU1674673428.USD","SG9999014567.USD","LU0648001328.SGD","LU0158827948.USD","LU2468319806.SGD","LU0432979614.USD","LU1585245621.USD","LU0203347892.USD","LU2361044949.HKD","BK4559","LU0158827781.USD","LU2242652126.USD","LU1066051498.USD","LU2106854487.HKD","LU1064131342.USD","LU1323610961.USD","LU0289961442.SGD","LU2896262040.SGD","BK4566","AZN","LU0795875169.SGD","LU1674673691.USD","IHE","LU0057025933.USD","LU0210528500.USD","LU1291159041.SGD","LU2028103732.USD","ELIL","AMGN","IE0034235303.USD","IE00B3PB1722.GBP","JNJ","LU2236285917.USD","LU2505996681.GBP","LU1244550577.SGD","LU2125909593.SGD","LU0545039389.USD","LU0198837287.USD","BK4592","SG9999014880.SGD","LU0097036916.USD","LU0320765059.SGD","LU0354030511.USD","LU0124676726.USD","BK4007","LU2471134952.CNY","LU1496350171.SGD","OZEM","IE000SO60NU8.SGD","LU2592432038.USD","LU0795875086.SGD","LU0738911758.USD","IE00B1XK9C88.USD","LU2108987350.USD","PFE","LU1037948541.HKD","LU0472753341.HKD","MRK","IE0004445239.USD","SG9999011175.SGD","LU1074936037.SGD","BMY","LU0792757196.USD","LU1267930730.SGD","LU2089284900.SGD","LU1244550494.USD","LU0058720904.USD","LU0109391861.USD","LU0256863902.USD","LU0426412945.USD","BMED","LU2347655073.USD","IE0002141913.USD","LU2023250504.SGD","LU1023059063.AUD","SG9999015978.USD","LU1121112475.USD","LU0289739343.SGD","BK4532","IE00B4JS1V06.HKD","LU0640476718.USD","LU2361045086.USD","LU1127390331.HKD","GB00BDT5M118.USD","IE00BN8TJ469.HKD","IE00BKDWB100.SGD","TBXU","LU0553294199.USD","LU0942090050.USD","IXJ","LU0061475181.USD","LU2112291526.USD","LU0203345920.USD","PAWZ","LU1917777945.USD","SG9999015945.SGD","LU1261432733.SGD","FTXH","LU2087621335.USD","CSL.AU","LU1868836914.USD","LU2471134796.USD","WDNA","LU2462591350.SGD","SG9999015358.SGD","LU2471134523.USD","IE00B7SZLL34.SGD","LU2237443465.HKD","LU1894683348.USD","BK7511","LU0210536198.USD","BK4599","IE00BFSS7M15.SGD","LU0466842654.USD","IE000BZT7R73.USD","LU2168564222.USD","LU0321505868.SGD","IYH","LU2023251221.USD","LU0133085943.USD","LU2125154935.USD","IE00BFXG1179.USD","SG9999013999.USD","TRUH","GLAM","LU1003077747.HKD","LU0211331839.USD","IE00B894F039.SGD","LU1804176565.USD","LU0072461881.USD","LU0203201768.USD","LU0265550359.USD","LU1670711123.USD","LU1989772840.SGD","LU2417539215.USD","LU2462157665.USD","LU0965508806.USD","LU2491050071.SGD","BK4504","LU1069347547.HKD","LU1699723380.USD","LU0234570918.USD","IE00BK4W5L77.USD","LU0820561818.USD","LU0353189680.USD","LU0889565916.HKD","LU0096364046.USD","LU1196500208.SGD","LU0310799852.SGD","LU1670710661.SGD","LU1974910355.USD","IE00B19Z9P08.USD","LU0345770308.USD","LU2430703178.SGD","LU1043141123.HKD","LU1366192091.USD","LLYZ","LU1914381329.SGD","LU1430594728.SGD","LU2237443549.SGD","SG9999015341.SGD","LU2360032135.SGD","LU0320765992.SGD","IE00BSNM7G36.USD","LU1032466523.USD","LU2552382058.USD","LU2756315318.SGD","BK4533","IBB","LU0306806265.USD","LU1778281490.HKD","BK4516","LU1720051108.HKD","LU1059921491.USD","LU2357305700.SGD","BK4550","LU2237443895.HKD","IE000M9KFDE8.USD","LU0823434583.USD","LU1069344957.HKD","LU0477156953.USD","SG9999014914.USD","LU0689472784.USD","LU1116320901.HKD","LU2750360641.GBP","LU2237443622.USD","LU1670627923.USD","BK4578","LU1935042991.SGD","LU1057294990.SGD","LU0320765489.SGD","LU0994945656.USD","XLV","LU1037948897.HKD","IE00BVYPNW00.USD","RXL","SGXZ57979304.SGD","LU2756315664.SGD","IE00B42XCP33.USD","LU0109394709.USD","LU1066051225.USD","LU1506573853.SGD","LU2213496289.HKD","SG9999014559.SGD","SGXZ51526630.SGD","GSK","GSKH","LU0417517546.SGD","LU0882574139.USD","IE00BJT1NW94.SGD","LU0882574055.USD","AGNG","LU1267930490.SGD","LU0820562030.AUD","LLYX","LU1116320737.USD","LU1868837136.USD","LU0964807845.USD","IE00BK4W5M84.HKD","LU1221951046.USD","LU2347655156.SGD","TMED","IE00BVYPNV92.GBP","LU0306807586.USD","LU0345769128.USD","IE0005OL40V9.USD","SG9999014906.USD","IE00BLSP4239.USD","LU0225284248.USD","LU0786609619.USD","LU1232071149.USD","LU1043141396.HKD","IBBQ","LU0689626769.HKD","IE00BBT3K403.USD","LU0965509101.SGD","LU0861579265.USD","LU1829250122.USD","LU1496350502.SGD","BK4139","LU1221951129.SGD","SG9999003800.SGD","IE0009355771.USD","IE00BJJMRX11.SGD","LU0203202063.USD","LU0868494708.USD","PBE","LU2456880835.USD","LU0098860793.USD","VHT","LU0980610538.SGD","LU0385154629.USD","LU0265550946.USD","LU0094547139.USD","LU2746668461.USD","BK4534","LU1839511570.USD","LU0471298694.HKD","LU2133065610.SGD","LU2360106947.USD","LU0321505439.SGD","IE00B7KXQ091.USD","IE00BKVL7J92.USD","GDOC","LU1035775433.USD","LU0237698245.USD","LU1934455863.HKD","LU0820561909.HKD","LU2129689605.HKD","LU1032955483.USD","LU0320765646.SGD","IE00BJJMRZ35.SGD","SGXZ81514606.USD","IE00B775H168.HKD","LU0683600562.USD","LU2237443978.SGD","LU0234572021.USD","BK7067","LU1061106388.HKD","FHLC","BK4581","LU1201861249.SGD","ABBV","LU0708995401.HKD","LU0114720955.EUR","LU0208291251.USD","LU0471298777.SGD","LU0868494617.USD","LU2271345857.HKD","IE0001KFT4U8.USD","LU1551013342.USD","LU0985320562.USD","LU0545562505.USD","LU1267930813.SGD","SG9999001176.SGD","LU1228905037.USD","SG9999014898.SGD","IE00BJJMRY28.SGD","IE000MB6IJN5.SGD","LU2461242641.AUD","HRTS","LU2129689431.USD","LU2491049909.HKD","LU0943347566.SGD","IE00BFTCPJ56.SGD","LU2089283258.USD","LU0345769631.USD","IE00BFSS8Q28.SGD","LU1162221912.USD","LU1623119135.USD","LU1934455194.USD","BK4583","LU2168564149.EUR","LU1145028129.USD","IE0002270589.USD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657529622","title":"GSK’s NEBULA-1 MASH Cirrhosis Trial: A New Catalyst in Metabolic Liver Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657529622?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:31","pubTimestamp":1785947469,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The NEBULA-1 phase 3 study from GlaxoSmithKline aims to test efimosferm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-nebula-1-mash-cirrhosis-trial-a-new-catalyst-in-metabolic-liver-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-nebula-1-mash-cirrhosis-trial-a-new-catalyst-in-metabolic-liver-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4585","GSK","GSKH","BK4007","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656552722","title":"GSK's New Drug Launches Will be Key to 2027 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2656552722","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656552722?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:38","pubTimestamp":1785854280,"startTime":"0","endTime":"0","summary":"1438 GMT - GSK's newly launched drugs will be key to reduce risk on the U.K. pharmaceutical company's outlook for next year, analysts at J.P. Morgan say. GSK recently launched blood-cancer drug Blenrep and asthma treatment Exdensur, while lung-cancer medicine Jideytro--which the company bought through its acquisition of Nuvalent--received U.S. approval last month. The trajectory of these products and others that are expected to reach the market next year like hepatitis B drug bepirovirsen and neladalkib--another lung-cancer drug from Nuvalent--will be increasingly focus for investors, the analysts say. The company's efforts to accelerate its strategy look encouraging but, with the next pivotal study results due to come only in 2028, potential risks to earnings in the near term might draw investors' attention, they add. Shares rise 0.2%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GSK's New Drug Launches Will be Key to 2027 Outlook","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GSK","LU1829250122.USD","GSK.UK","BK4007","BK4532","BK4585","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656535373","title":"GlaxoSmithKline (GSK) Receives a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2656535373","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656535373?lang=en_us&edition=fundamental","pubTime":"2026-08-04 15:57","pubTimestamp":1785830258,"startTime":"0","endTime":"0","summary":"In a report released today, James Gordon CFA from Barclays maintained a Sell rating on GlaxoSmithKline, with a price target of £19.00. According to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-sell-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-sell-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSK","BK4532","BK4588","GSK.UK","GSKH","LU1829250122.USD","CFA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655804705","title":"GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2655804705","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655804705?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:32","pubTimestamp":1785429167,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running a Phase 1 trial called “A Phase 1, Observer-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-toddler-pneumococcal-booster-signaling-ongoing-vaccine-pipeline-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-toddler-pneumococcal-booster-signaling-ongoing-vaccine-pipeline-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSKH","BBC","BK4588","BK4007","GSK.UK","LU1829250122.USD","GSK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655066588","title":"GSK Supply Chain President Registers Sale of Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2655066588","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655066588?lang=en_us&edition=fundamental","pubTime":"2026-07-30 22:32","pubTimestamp":1785421948,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK disclosed that Regis Simard, the company’s President of Global Supply Chain, has sold 38,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-supply-chain-president-registers-sale-of-ordinary-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-supply-chain-president-registers-sale-of-ordinary-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1829250122.USD","GSK.UK","BK4588","BK4532","GSKH","BK4007","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655894955","title":"GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2655894955","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655894955?lang=en_us&edition=fundamental","pubTime":"2026-07-29 23:27","pubTimestamp":1785338827,"startTime":"0","endTime":"0","summary":"GSK's  majority-owned ViiV Healthcare unit reported trial data that back Cabenuva's, also known as cabotegravir plus rilpivirine, potential as a long-acting injectable HIV treatment, according to a Wednesday statement.The LATA trial's week 96 results demonstrated Cabenuva's superiority over daily oral therapy in 476 virologically suppressed adolescents of ages 12 to 19 years with HIV in certain African countries, GSK said. Meanwhile, data from the US-based OPERA cohort showed that Cabenuva maintained virologic suppression comparable with daily oral therapy in 6,800 adults with HIV, GSK added.GSK also said six-month follow-up data from the phase 1 CLARITY trial supported a \"more favorable\" injection experience with long-acting cabotegravir, compared with lenacapavir, after a single dose.The company is also investigating an intramuscular formulation of cabotegravir dosed three times a year for HIV prevention, with data to be presented at a future medical event, according to the statement","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0029874061.USD","GSK","BK4588","BK4532","GSKH","XBI","LU0128526141.USD","LU1829250122.USD","BK4137","BK4581","GSK.UK","BK4007","LABU","BK4585","HCSG","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655997158","title":"Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2655997158","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655997158?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:25","pubTimestamp":1785335147,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK with Shionogi as a shareholder, announced data to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cabenuva-demonstrates-superiority-to-daily-oral-therapy-in-adolescents-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cabenuva-demonstrates-superiority-to-daily-oral-therapy-in-adolescents-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1829250122.USD","BK4581","GSKH","XLV","GSK","GSK.UK","BK4532","BK4585","LABU","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}